Garonit Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company.
One of their notable products is CHLORHEXIDINE GLUCONATE SOLUTION USP 20%, with a corresponding US DMF Number 25417.
Remarkably, this DMF maintains an Active status since its submission on October 17, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 16, 2025, and payment made on September 04, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II